GO:0071716 leukotriene transport: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0071716 leukotriene transport describes the directed movement of leukotrienes into, out of, or within cells by transporters or pores.
• Leukotriene C4 (LTC4) is a glutathione-conjugated eicosanoid exported by MRP1/ABCC1 and RLIP76/RALBP1.
• Leukotriene transport is essential for inflammatory signaling, including basophil-neuron-immune crosstalk in itch.
• In the central nervous system, LTC4 transport and metabolism are mediated by choroid plexus and brain barriers.
• Dysregulated leukotriene transport contributes to atherosclerosis, cancer drug resistance, and neuroinflammation.
• CRISPR knockout, knock-in, and overexpression models enable causal dissection of leukotriene transporter genes.
Description
Leukotriene transport (GO:0071716) is the biological process by which leukotrienes, a family of linear C20 arachidonic acid-derived lipid mediators, are moved into, out of, or within cells via transporters or pores. Leukotrienes contain a terminal carboxy function and four or more double bonds, three or more of which are conjugated, making them amphipathic molecules that require facilitated transport rather than simple diffusion. This process is fundamental to inflammatory signaling because leukotrienes must reach extracellular receptors to exert their biological effects. The export of leukotriene C4 (LTC4) by ATP-binding cassette (ABC) transporters such as MRP1/ABCC1 and by RLIP76/RALBP1 is a well-characterized example of leukotriene transport. In the central nervous system, LTC4 transport and metabolism have been studied in choroid plexus and brain tissue, highlighting the importance of transport in neuroinflammatory contexts. Recent work has identified a basophil-neuronal axis in which leukotriene transport and signaling promote itch, linking this GO term to sensory neuroimmunology. Understanding leukotriene transport is therefore critical for researchers studying inflammation, cancer, cardiovascular disease, and neurological disorders.
leukotriene transport At A Glance
| GO ID | GO:0071716 |
|---|---|
| GO term | leukotriene transport |
| Ontology | biological_process |
| Synonym | None |
| Major function | Directed movement of leukotrienes across membranes via transporters or pores |
| Representative transporters | MRP1/ABCC1, RLIP76/RALBP1 |
| Substrates | Leukotriene C4 (LTC4) and structurally related conjugates |
| Tissue contexts | Choroid plexus, brain, immune cells, cancer cells |
| Disease relevance | Atherosclerosis, cancer drug resistance, neuroinflammation, itch |
What Is GO:0071716?
GO:0071716 leukotriene transport is defined as the directed movement of leukotrienes into, out of, or within a cell, or between cells, by means of some agent such as a transporter or pore. Leukotrienes are linear C20 endogenous metabolites of arachidonic acid (icosa-5,8,11,14-tetraenoic acid) containing a terminal carboxy function and four or more double bonds (three or more of which are conjugated) as well as other functional groups. This process encompasses the translocation of leukotrienes across membranes, which is required for their autocrine and paracrine signaling functions.
Why Is leukotriene transport Important in Cell Biology?
Leukotriene transport is important because leukotrienes are potent lipid mediators of inflammation that must be transported across cellular membranes to reach their receptors and exert biological effects. The transport process determines the local concentration and duration of leukotriene signaling, influencing vascular tone, immune cell recruitment, and neuronal activation. In cancer, leukotriene transport mediated by RLIP76/RALBP1 contributes to drug resistance, making it a potential therapeutic target. In the central nervous system, LTC4 transport and metabolism at the choroid plexus and brain barriers affect neuroinflammation and clearance of lipid mediators. Thus, understanding leukotriene transport provides mechanistic insight into diverse physiological and pathological processes.
• Leukotriene transport enables extracellular leukotriene signaling by moving LTC4 and related conjugates out of cells.
• MRP1/ABCC1-mediated LTC4 transport is a glutathione-dependent process linked to multidrug resistance.
• RLIP76/RALBP1 transports LTC4 in cancer cells and contributes to chemotherapeutic drug resistance.
• Leukotriene transport in the choroid plexus influences central nervous system lipid mediator homeostasis.
• LTC4 transport and metabolism in the brain are relevant to neuroinflammation and neurodegeneration.
• A basophil-neuronal axis involving leukotriene transport promotes itch, linking transport to sensory biology.
• Leukotriene receptors and transport are implicated in atherosclerosis and cardiovascular disease.
• Prostaglandin transport studies provide comparative insight into eicosanoid transporter biology.
• Targeting leukotriene transport may overcome drug resistance in cancer therapy.
• CRISPR-based models allow causal testing of transporter genes in leukotriene transport.
What Happens During leukotriene transport?
Leukotriene synthesis and conjugation
In simple terms: Cells first make leukotrienes and attach a glutathione tag to LTC4.
Leukotriene transport begins with the synthesis of leukotrienes from arachidonic acid. LTC4 is formed by conjugation of leukotriene A4 with glutathione, producing a cysteinyl leukotriene that is a substrate for dedicated transporters. This conjugation is essential for recognition by ATP-binding cassette transporters such as MRP1/ABCC1.
Transporter recognition and binding
In simple terms: Specific transporter proteins recognize LTC4 and bind it for export.
MRP1/ABCC1 binds LTC4 in a glutathione-dependent manner, and this binding is required for transport. RLIP76/RALBP1 also binds LTC4 and mediates its transport in cancer cells. The specificity of these interactions determines which leukotrienes are transported and at what rate.
Translocation across the membrane
In simple terms: The transporter moves LTC4 across the cell membrane to the outside.
ATP-binding cassette transporters such as MRP1/ABCC1 use ATP hydrolysis to translocate LTC4 across the plasma membrane. RLIP76/RALBP1-mediated transport also requires energy and is saturable, indicating a protein-mediated process. In the choroid plexus, vectorial transport of ligands including leukotrienes occurs across epithelial barriers.
Extracellular signaling and metabolism
In simple terms: Once outside, leukotrienes bind receptors or are metabolized.
Exported LTC4 can bind cysteinyl leukotriene receptors to trigger inflammatory responses. In the central nervous system, LTC4 is transported and metabolized, limiting its action. A basophil-neuronal axis uses leukotriene transport and signaling to promote itch, demonstrating a physiological outcome of this process.
Clearance and termination
In simple terms: Leukotrienes are eventually removed or broken down to stop signaling.
Transport also contributes to clearance of leukotrienes from the extracellular space. In the brain, LTC4 transport and metabolism in the choroid plexus and central nervous system help terminate leukotriene signals. Prostaglandin transport studies provide a comparative framework for understanding eicosanoid clearance.
Key Genes Involved in GO:0071716 leukotriene transport
The following genes and proteins are experimentally implicated in leukotriene transport, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ABCC1 (MRP1) | ATP-dependent export of LTC4 and chemotherapeutic agents | Glutathione-dependent transport; drug resistance studies |
| RALBP1 (RLIP76) | Mediates LTC4 transport in cancer cells | Target for overcoming drug resistance |
| ABCC4 (MRP4) | Related eicosanoid transport | Comparative transporter biology |
| SLCO2A1 | Prostaglandin transport; related eicosanoid transport | Eicosanoid transport mechanisms |
| SLCO1A2 | Organic anion transport; related eicosanoid transport | Substrate specificity studies |
| ALOX5 | Leukotriene biosynthesis upstream of transport | Pathway context for transport |
| ALOX5AP | Leukotriene biosynthesis | Inflammatory pathway studies |
| LTC4S | Synthesis of LTC4, the transported substrate | Substrate availability for transport |
| GGT1 | Metabolism of LTC4 to LTD4 | Leukotriene processing |
| DPEP1 | Metabolism of leukotrienes | Leukotriene inactivation |
| CYSLTR1 | Receptor for cysteinyl leukotrienes | Signaling after transport |
| CYSLTR2 | Receptor for cysteinyl leukotrienes | Signaling after transport |
| ABCB1 (MDR1) | Related ABC transporter | Multidrug resistance context |
| ABCC2 (MRP2) | Related ABC transporter | Transport comparative studies |
| SLC22A8 | Organic anion transporter; related eicosanoid transport | Transport specificity |
| SLC22A6 | Organic anion transporter; related eicosanoid transport | Transport specificity |
| SLC22A12 | Urate transporter; related organic anion transport | Comparative transport |
How Is leukotriene transport Regulated?
Leukotriene transport is regulated at multiple levels. MRP1/ABCC1-mediated LTC4 transport is glutathione-dependent, meaning that intracellular glutathione levels modulate transport activity. RLIP76/RALBP1-mediated transport is saturable and energy-dependent, suggesting regulation by substrate availability and cellular energy status. In the choroid plexus, vectorial transport of ligands including leukotrienes is subject to regulation by transport inhibitors and physiological conditions. In the central nervous system, LTC4 transport and metabolism are regulated by enzymatic degradation and barrier function. Additionally, inflammatory stimuli that induce leukotriene synthesis also increase substrate availability for transport.
leukotriene transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ABCC1 (MRP1) | Cancer drug resistance | Knockout in cancer cell lines; drug sensitivity assays |
| RALBP1 (RLIP76) | Cancer drug resistance | Overexpression and knockout in cancer cells |
| CYSLTR1 | Atherosclerosis | Knockout mouse models; vascular inflammation assays |
| LTC4S | Inflammatory disease | Knockout models; leukotriene production assays |
| ABCC4 (MRP4) | Eicosanoid transport | Knockout and transport assays |
Leukotriene transport in cancer and drug resistance
MRP1/ABCC1 and RLIP76/RALBP1 transport LTC4 and chemotherapeutic agents, contributing to multidrug resistance in cancer cells. Overexpression of these transporters reduces intracellular drug accumulation, limiting the efficacy of vincristine and other agents. Targeting leukotriene transport pathways may restore chemosensitivity.
Leukotriene transport in atherosclerosis and cardiovascular disease
Leukotriene receptors and transport are implicated in atherosclerosis, where leukotrienes promote vascular inflammation and smooth muscle proliferation. Transport determines the availability of leukotrienes to activate receptors on endothelial and immune cells. Modulating transport could influence plaque progression.
Leukotriene transport in neuroinflammation and itch
In the central nervous system, LTC4 transport and metabolism occur in the choroid plexus and brain, affecting neuroinflammatory responses. A basophil-neuronal axis involving leukotriene transport promotes itch, linking transport to sensory neuroimmunology. These findings suggest that transport inhibitors could modulate neurogenic inflammation.
From leukotriene transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does ABCC1 mediate LTC4 transport? | ABCC1 knockout cell lines with LTC4 transport assays |
| Does RLIP76 contribute to drug resistance? | RLIP76 overexpression and knockout in cancer cells |
| What is the role of LTC4 transport in itch? | Conditional knockout in sensory neurons |
| How does choroid plexus transport leukotrienes? | In vitro choroid plexus epithelial models |
| Does LTC4 transport affect brain inflammation? | Brain-specific knockout of transporters |
| Can point mutations alter transporter specificity? | Knock-in of mutant transporter alleles |
How to Study the leukotriene transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Membrane vesicle transport assay | ATP-dependent LTC4 transport | MRP1/ABCC1 and RLIP76 function |
| CRISPR knockout | Loss-of-function effects on transport | Causal gene validation |
| Overexpression | Gain-of-function transport activity | Transporter sufficiency |
| Lipidomics | Leukotriene species quantification | Substrate and product analysis |
| Immunofluorescence | Transporter localization | Choroid plexus and barrier studies |
| In vivo itch models | Behavioral itch responses | Basophil-neuron axis |
| Brain slice transport | LTC4 transport and metabolism | Neuroinflammation studies |
Transport assays with radiolabeled leukotrienes
Membrane vesicle transport assays using radiolabeled LTC4 are used to measure ATP-dependent transport by MRP1/ABCC1 and RLIP76/RALBP1. These assays quantify substrate accumulation and are suitable for kinetic analysis.
CRISPR knockout and overexpression
CRISPR knockout of ABCC1 or RALBP1 followed by transport assays can establish causality. Overexpression of candidate transporters in naive cells can confer transport activity.
In vivo models of inflammation and itch
Mouse models of itch and inflammation can be used to test the role of leukotriene transport in basophil-neuron crosstalk. Choroid plexus and brain models assess central nervous system transport.
Metabolic and lipidomics profiling
Mass spectrometry-based lipidomics can quantify leukotriene species in cells and tissues after genetic manipulation of transporters. This approach reveals changes in substrate availability and clearance.
How CRISPR Can Be Used to Study GO:0071716 leukotriene transport
Knockout
CRISPR knockout of ABCC1 or RALBP1 can eliminate leukotriene transport activity, allowing researchers to test whether these transporters are required for LTC4 export and downstream signaling. Knockout models are essential for establishing causality in transport pathways.
Point Mutation
Point mutations in transporter genes can be introduced to dissect substrate binding sites and ATP hydrolysis domains. Such models help determine how specific residues affect LTC4 recognition and transport kinetics.
Knock-in
Knock-in of tagged or mutant transporters enables visualization and functional analysis of leukotriene transport in native contexts. Tagged knock-in models can be used for localization and interaction studies.
Overexpression
Overexpression of ABCC1 or RALBP1 in cell lines can confer leukotriene transport activity and drug resistance, providing a gain-of-function system to study transport mechanisms. Overexpression models are useful for testing inhibitors.
How EDITGENE Supports leukotriene transport Research
Researchers studying leukotriene transport-related genes often need to determine whether a candidate gene is causally involved in LTC4 export, drug resistance, or neuroinflammation. EDITGENE provides CRISPR-based cell models and screening services to accelerate this discovery process.
Contact EDITGENE today to design your custom CRISPR model for leukotriene transport research.
Frequently Asked Questions About leukotriene transport
What is leukotriene transport?
Leukotriene transport (GO:0071716) is the directed movement of leukotrienes into, out of, or within cells by transporters or pores.
What genes are involved in leukotriene transport?
Key genes include ABCC1 (MRP1) and RALBP1 (RLIP76), which transport LTC4.
How is LTC4 transported out of cells?
LTC4 is exported by ATP-binding cassette transporters such as MRP1/ABCC1 in a glutathione-dependent manner.
What is the role of RLIP76 in leukotriene transport?
RLIP76/RALBP1 mediates LTC4 transport in cancer cells and contributes to drug resistance.
Is leukotriene transport involved in itch?
Yes, a basophil-neuronal axis involving leukotriene transport promotes itch.
How is leukotriene transport studied?
Membrane vesicle transport assays, CRISPR knockout, and lipidomics are common methods.
What diseases are linked to leukotriene transport?
Cancer drug resistance, atherosclerosis, and neuroinflammation are linked to leukotriene transport.
Does leukotriene transport occur in the brain?
Yes, LTC4 transport and metabolism occur in the choroid plexus and central nervous system.
What is the GO ID for leukotriene transport?
The GO ID is GO:0071716.
Can CRISPR be used to study leukotriene transport?
Yes, CRISPR knockout and knock-in models can dissect transporter gene function.
Conclusion
Leukotriene transport (GO:0071716) is a critical biological process that controls the availability of leukotrienes for receptor signaling, with profound implications for inflammation, cancer, and neurological disease. The identification of MRP1/ABCC1 and RLIP76/RALBP1 as LTC4 transporters has provided molecular entry points for studying this process. Emerging evidence links leukotriene transport to itch and neuroimmune crosstalk, expanding its physiological relevance. Continued research using CRISPR models and transport assays will clarify how these transporters are regulated and how they can be targeted therapeutically.
References
- 1. Wang F et al.. 2021. A basophil-neuronal axis promotes itch.. Cell 184(2):422-440.e17 PMID: 33450207
- 2. Jedlitschky G et al.. 2002. Transport of leukotriene C4 and structurally related conjugates.. Vitam Horm 64:153-84 PMID: 11898391
- 3. Schuster VL. 2002. Prostaglandin transport.. Prostaglandins Other Lipid Mediat 68-69:633-47 PMID: 12432949
- 4. Bäck M et al.. 2006. Leukotriene receptors in atherosclerosis.. Ann Med 38(7):493-502 PMID: 17101540
- 5. Loe DW et al.. 1996. Multidrug resistance protein (MRP)-mediated transport of leukotriene C4 and chemotherapeutic agents in membrane vesicles. Demonstration of glutathione-dependent vincristine transport.. J Biol Chem 271(16):9675-82 PMID: 8621643
- 6. Sharma R et al.. 2004. RLIP76 (RALBP1)-mediated transport of leukotriene C4 (LTC4) in cancer cells: implications in drug resistance.. Int J Cancer 112(6):934-42 PMID: 15386349
- 7. Spector R et al.. 2010. Vectorial ligand transport through mammalian choroid plexus.. Pharm Res 27(10):2054-62 PMID: 20473558
- 8. Spector R et al.. 1986. Leukotriene C4 transport and metabolism in the central nervous system.. J Neurochem 46(4):1308-12 PMID: 3081687
